In a population-based study of 133 schizophrenia patients, cannabis use independently predicted earlier onset of psychosis, with male cannabis users developing their first psychotic episode 6.9 years younger than male non-users.
Read this if you want to understand the research linking cannabis use to earlier onset of schizophrenia, especially in men.
Male cannabis users were 6.9 years younger at first psychotic episode than male non-users
What the researchers found
Researchers conducted a population-based, first-contact incidence study in The Hague, Netherlands, examining 133 schizophrenia patients. They looked at three milestones: first social/occupational dysfunction, first psychotic episode, and first negative symptoms.
Male patients reached all three milestones at significantly younger ages than female patients. Cannabis-using patients also reached these milestones significantly younger than non-users.
In multivariate analysis, cannabis use, but not gender, independently predicted the age of first psychotic episode. Male cannabis users were a mean of 6.9 years younger at illness onset than male non-users. However, gender rather than cannabis use predicted the age of first social/occupational dysfunction and the risk of developing negative symptoms before treatment.
Why it matters
The finding that cannabis use independently predicted earlier onset of psychosis, even after controlling for gender differences, adds to evidence of a specific relationship between cannabis and the timing of psychotic episodes. The 6.9-year difference is clinically substantial, as earlier onset is generally associated with worse long-term outcomes.
The numbers in context
133 schizophrenia patients studied. Male cannabis users were 6.9 years younger at first psychotic episode than male non-users. Cannabis use, but not gender, independently predicted age at first psychotic episode in multivariate analysis.
How the study worked
Population-based, first-contact incidence study conducted in The Hague, Netherlands. One hundred thirty-three patients were interviewed using the Comprehensive Assessment of Symptoms and History. Key informants were interviewed with the Instrument for the Retrospective Assessment of the Onset of Schizophrenia. Multivariate analyses controlled for the independent effects of gender and cannabis use on three illness milestones.
What this study cannot tell us
The cross-sectional design cannot establish causation. Cannabis use was assessed retrospectively, which introduces recall bias. The study cannot determine whether cannabis use precipitated psychosis in individuals who would not have developed it otherwise or simply accelerated onset in those already predisposed.
How to read the evidence
Population-based incidence study with multivariate analysis, providing stronger evidence than clinic-based samples, though still unable to establish causation.
When this study was published
Published in 2004. Subsequent longitudinal studies have further examined the cannabis-psychosis relationship, generally supporting the association with earlier onset.
The bigger picture
This study is part of a growing body of evidence suggesting cannabis use is associated with earlier onset of schizophrenia, particularly in males. The population-based design strengthens the finding compared to clinic-based samples. Whether this represents a causal effect of cannabis or reflects shared vulnerability factors continues to be debated.
Questions still open
- Does the earlier onset associated with cannabis use lead to worse long-term outcomes? Would earlier intervention in cannabis-using individuals at risk for psychosis delay or prevent the first psychotic episode?
Common questions
Does cannabis cause schizophrenia?
Were women also affected by cannabis use?
Read the original research
Cannabis use and age at onset of schizophrenia.
The American journal of psychiatry, 161(3), 501-6
Citation
Veen, Natalie D; Selten, Jean-Paul; van der Tweel, Ingeborg; Feller, Wilma G; Hoek, Hans W; Kahn, René S. (2004). Cannabis use and age at onset of schizophrenia.. The American journal of psychiatry, 161(3), 501-6.
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)
- THC and Antipsychotics: A Complicated Relationship